Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

FOXO4-DRI | FOXO4/p53 Interaction Blocker

Cat. No.: HY-P4157 1 Cited Publications Customer Review Based on 1 publication(s) in Google Scholar FOXO4-DRI is a cell-permeable peptide antagonist that blocks the interaction of FOXO4 and p53. FOXO4-DRI is a senolytic peptide that induces apoptosis of senesc

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Cat. No.: HY-P4157

1 Cited Publications

Customer Review

Based on 1 publication(s) in Google Scholar

FOXO4-DRI is a cell-permeable peptide antagonist that blocks the interaction of FOXO4 and p53. FOXO4-DRI is a senolytic peptide that induces apoptosis of senescent cells.

For research use only. We do not sell to patients.

  • Purity: 99.96%
  • CAS No.: 2460055-10-9
  • Formula: C228H388N86O64
  • Molecular Weight:5358.06
  • Storage:

    Sealed storage, away from moisture.

    Powder   -80°C, 2 years , -20°C, 1 year

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

Keywords

MOQ

Minimum order quantity

100 mg

Get Quote In-stock

Other size

Get Quote

Please select quantity

Amount: USD 0.00

Sign in to MedChemExpress Sign In

Register

Register New Account

At least 6 characters

Assay Types

P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →